Avantor unveils $500M share buyback initiative
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 29 2025
0mins
Should l Buy AVTR?
Share Repurchase Program: Avantor's Board has authorized a new $500 million share repurchase program, reflecting confidence in the company's growth and profitability potential.
Commitment to Shareholders: CEO Ligner expresses strong belief in the company's future performance and is implementing changes aimed at delivering positive results for shareholders.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AVTR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AVTR
Wall Street analysts forecast AVTR stock price to rise
7 Analyst Rating
1 Buy
4 Hold
2 Sell
Hold
Current: 8.780
Low
8.00
Averages
11.67
High
16.00
Current: 8.780
Low
8.00
Averages
11.67
High
16.00
About AVTR
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Oversold Stock List: A search using the Benzinga Pro Scanner identified stocks with market caps over $2 billion and RSI below 30, with KraneShares CSI China Internet ETF (KWEB) showing an RSI of 18.32, indicating extreme oversold conditions that may lead to a rebound if risk appetite improves.
- JD.com Performance: JD.com has an RSI of 24.42, with shares around $25.21, down 1.68% on the day, reflecting the overall pressure on Chinese consumer and internet stocks, potentially providing short-term trading opportunities for investors.
- Broad Market Overselling: iShares China Large-Cap ETF (FXI) posts an RSI of 24.99, trading near $35.89, indicating that selling pressure has broadened from individual stocks to major Chinese benchmarks, which may influence investors' regional allocation decisions.
- Emerging Market Signals: iShares MSCI India ETF (INDA) shows an RSI of 29.75, trading around $50.03, indicating oversold conditions and suggesting that selling pressure has spread to broader Asian and emerging markets, potentially prompting long-term investors to reassess their risk tolerance.
See More
- Alpha Metallurgical Resources: The mining company has seen its current year earnings estimate revised down by nearly 18.8% over the past 60 days, indicating significant pressure on profitability that may affect investor confidence.
- Amerant Bancorp: This bank holding company has had its current year earnings estimate cut by 10.9% in the last 60 days, suggesting a potential slowdown in business growth, prompting investors to reassess risks.
- Avantor: The global provider's current year earnings estimate has been revised down by almost 9% over the past 60 days, reflecting a possible weakening demand in the biopharma and healthcare sectors, which could impact future performance.
- Investment Opportunities: While these stocks are categorized as strong sells, other stocks recommended by Zacks experts have previously soared by up to 232%, presenting potential rebound opportunities for investors.
See More
- Software Selloff: After three consecutive days of gains, the iShares Tech-Expanded Software Sector ETF (NYSE:IGV) fell over 3% on Wednesday, indicating a decline in market confidence towards the software sector, which could impact investor sentiment towards tech stocks overall.
- Strong Jobs Data but Severe Revisions: Although January's nonfarm payrolls rose by 130,000, significantly exceeding economists' expectations of 70,000, the total U.S. job growth for 2025 was drastically revised down to just 181,000, highlighting the fragility of economic recovery and potentially raising concerns about future growth.
- Unexpected Drop in Unemployment Rate: The unemployment rate fell from 4.4% to 4.3%, which appears positive on the surface; however, this contrasts sharply with the downward revisions in job growth, possibly leading investors to question the economic outlook.
- Robinhood's Poor Market Performance: Robinhood Markets Inc. (NASDAQ:HOOD) saw its stock tumble 12% following a revenue miss and disappointing cryptocurrency trading results, reflecting market concerns about its future profitability and potentially undermining investor confidence.
See More
- Weak Earnings Guidance: Avantor's forecast for 2026 earnings falls short of market expectations, leading to a decline in share price, which reflects investor concerns about the company's future performance and may undermine confidence.
- Revenue Decline Expected: The company anticipates a decrease in future revenues, with analysts suggesting that this trend could negatively impact the overall financial health of Avantor, potentially leading to further stock price pressure.
- CEO Turnaround Plan: Avantor's CEO has outlined a turnaround strategy to address margin pressures, aiming to improve financial conditions through operational optimization and cost control, thereby restoring market trust.
- Analyst Perspectives: Analysts generally believe that the current stock discount is justified, reflecting a cautious market outlook on the company's future profitability, which may influence investor buying decisions.
See More
- Sales Performance Decline: Avantor reported sales of $1.66 billion, slightly above the consensus of $1.64 billion, yet reflecting a year-over-year decline of 1.4%, indicating pressure in a competitive market that impacts investor confidence.
- Organic Sales Drop: Despite a positive foreign currency impact of 3.1%, the negative 0.4% from M&A led to a 4.1% decline in organic sales, highlighting challenges in core operations that could affect future growth potential.
- Profitability Outlook: Avantor expects adjusted earnings per share for fiscal 2026 to range between $0.77 and $0.83, below the consensus of $0.90, indicating pressure on profitability that may raise investor concerns about future performance.
- Market Performance Assessment: Analyst William Blair notes Avantor's shares trade at 11.4 times the midpoint of the 2026 adjusted EBITDA guide, lower than peers at 17.6 times, reflecting cautious market sentiment regarding its growth and margin profile, potentially affecting stock recovery.
See More

- Strategic Reorganization: Avantor announced a restructuring into two new business units after three months of implementing its revival plan, aiming to enhance market responsiveness through a customer-centric structure, thereby strengthening its competitive edge.
- Financial Performance: Q4 2025 revenue was $1.66 billion, down 4% year-over-year, with an adjusted gross margin of 31.5%, indicating profitability challenges amid market pressures, while management projects organic revenue decline of 2.5% to 0.5% for 2026.
- Investment Commitment: The company plans to invest $10 million to $15 million in 2026 to upgrade the VWR e-commerce platform, emphasizing the importance of digital transformation for customer engagement, aiming to enhance customer experience and market share.
- Market Outlook: Management's outlook for 2026 is cautious, with expected EBITDA margin contraction of 100 to 150 basis points due to investment and cost pressures, highlighting the challenges of maintaining profitability in an uncertain market environment.
See More







